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Abstract
Background: This study aimed to evaluate the effects of Gelam honey on corneal keratocytes proliferative capacity
and phenotypic characterization via MTT assay, gene expression and immunocytochemistry.
Methods: Corneal keratocytes from New Zealand white rabbits were cultured in basal medium (BM) and serum
enriched medium (BMS). Serial dilutions of Gelam honey (GH) were added to both media and cells were cultured
until passage 1. MTT assay was performed on corneal keratocytes in both media to ascertain the optimal dose of
GH that produced maximum proliferation.
Results: Gelam honey at the concentration of 0.0015 % in both media showed the highest proliferative capacity
with no morphological changes compared to their respective controls. The gene expression of aldehyde dehydrogenase
(ALDH), a marker for quiescent keratocytes and vimentin, a marker for fibroblast, were higher in the GH enriched
groups. The alpha smooth muscle actin (α-SMA) expression, marker for myofibroblast, was lower in GH treated
groups compared to the controls. Immunocytochemistry results were in accordance to the gene expression analyses.
Conclusion: Gelam honey at a concentration of 0.0015 % promotes ex vivo corneal keratocytes proliferation while
retaining desirable phenotype expression. The results serve as a basis for the development of Gelam honey as a
potential natural product in promoting corneal wound healing.
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Background
Cell proliferation is the key process in wound healing
and it involves several metabolic processes which require
much energy. Glucose is the main source of energy for
metabolism of most cells, either in vivo or ex vivo.
Honey is one of the natural products that is rich in
glucose and contains enzymes, amino acids, vitamins
and minerals [1]. It possesses medicinal properties
which include antimicrobial, antioxidant, antimuta-
genic, antitumour, anti-inflammatory and the capability
to stimulate cell proliferation [2]. Honey proliferative
effects on the in vivo study of the skin wound healing
were reported earlier [3–6]. However, to date, there is
lacunae in the existing scientific literature with regard
to the proliferative effects of honey on in vitro corneal
cells, particularly concerning Gelam honey (GH).
GH is one of the Malaysian monofloral honeys that is
found in bee hives of Gelam tree. It contains the highest
total phenols and flavonoid content [7]. The total sugar
content of GH was reported to be the highest among all
Malaysian monofloral honeys [8]. Previous research stud-
ies revealed that GH possessed the capability in accelerat-
ing skin wound healing [9–12]. In addition, GH has been
reported to increase the tensile strength of wounded der-
mal layer upon healing which is important in ensuring a
strong protective dermis [13]. GH is also reported to pos-
sess antibacterial effects [14], capable of minimising
oedema and pain sensation during inflammation [15]. It is
also reported to possess high antioxidant content [16]. To
the best of our knowledge, there are no reported studies
of GH on corneal injury. Since, the skin cells and the
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corneal cells are of epithelial in nature [17], it generates
much interest to study the effects of GH on corneal cells.
The present study used primary culture of rabbit cor-
neal keratocytes to evaluate the proliferative effects of
GH at the cellular level, via MTT assay, morphological
evaluation, gene and protein expression analyses. The re-
sults of the present study exhibited the positive role of
GH in promoting the proliferation and expression of de-
sirable ex vivo corneal keratocytes phenotypes. These
findings may be beneficial in the treatment of corneal
stroma wound healing.
Methods
This research was approved by the Universiti Kebangsaan




GH was obtained from the Apiary unit, Department of
Agriculture, Malaysia. The honey was aliquoted into sev-
eral air tight glass bottle containers and gamma irradi-
ated at 25 kGy [18] at the Malaysian Nuclear Agency.
The honey was then kept at room temperature.
Corneal keratocytes isolation and cell culture
Corneas from six New Zealand white strain rabbits (n =
6) were obtained from a local slaughterhouse and proc-
essed within 2 hours of post slaughtering [19]. The
corneas were extracted and ocular muscles, iris and
endothelium were removed. The loosened epithelial
layer was scraped off after immersing the corneas for
approximately 18 h in Dispase 2 mg/ml (Gibco Invitro-
gen, USA). Then, the stromal tissues were cut into
eight pieces and digested with 0.3 % Collagenase type I
(Gibco Invitrogen, USA) for about 2 hours at 37 °C in
a constant shaker at 200 rpm. Digested stroma and the
isolated keratocytes were centrifuged for 10 min at
500 g and the resultant cell pellet was washed thor-
oughly with phosphate buffered solution (PBS pH 7.2,
Gibco Invitrogen, USA).
Total cell quantification of corneal keratocytes was done
using Trypan blue dye (Gibco Invitrogen, USA) and
haemocytometer (Weber Scientific Int, England). The ker-
atocytes were then seeded at a density of 1 × 105 cells/cm2
in six well plates (BD Falcon, NJ) in basal medium with
serum (BMS), which consist of F12: DMEM (1:1 ratio)
(Gibco Invitrogen, USA), 10 % foetal bovine serum (FBS,
Gibco Invitrogen, USA) and 1 % of antibiotic-antimycotic
(Gibco Invitrogen, USA), vitamin C (Gibco Invitrogen,
USA) and Glumatax (Gibco Invitrogen, USA).
Cultures were kept in the incubator (Jouan Duguay
Troin, SH) at 37 °C, 5 % CO2 and 95 % humidity until
confluent. The medium was changed every 2 days. The
morphological changes and cell growth were observed
daily to detect signs of contamination. Upon confluence,
the cells were trypsinized with warm 0.125 % trypsin
EDTA (Gibco Invitrogen, USA). The cells were then
subcultured to passage 1.
MTT 3-[4, 5-dimethyl thiazolyl-2]-2, 5-diphenyl tetrazolium
bromide assay
MTT assay (Sigma-Aldrich) was used for quantitative
analysis of GH on corneal keratocytes proliferation and
viability. Corneal keratocytes from passage 1 were cul-
tured in BMS medium at the density of 5 × 103 cells/cm2
in a 96 well plate (Cellstar Greiner Bio-one, Germany).
After 24 h, the medium was replaced with basal medium
(BM) and new BMS medium supplemented with differ-
ent concentrations of GH in serial dilution from 0 to
1.56 %. The cells were incubated at 37 °C, 5 % CO2 and
95 % humidity for 48 h.
In brief, 10 μl of MTT solution was added into each
well and incubated for 4 h. MTT solution was then re-
moved and solubilized with 200 μl of dimethylsulfox-
ide (DMSO). Absorbance was measured at 570 nm by
Versamax Microplate Reader. GH which gave the highest
cell proliferation was chosen as the optimal concentration
for further tests involving protein and gene expression
analyses. The optimal dose of GH was identified at
0.0015 % concentration.
Gene expression analyses
Total RNA extraction was done using the TRIzol RNA
isolation method, based on manufacturer’s protocol.
An amount of 1 ml of TRI reagent solution (Molecular
Research Centre, USA) was added to all culture dishes
at Day 3 to lyse the cells. Then, 200 μl chloroform was
added to form phase separation. After that, 500 μl isopro-
panol and 5 μl polyacryl carrier (Molecular Research
Centre, USA) were added to precipitate total RNA. The
RNA pellet was then washed with 75 % ethanol and air
dried, before adding 20 μl Rnase and Dnase free distilled
water (Invitrogen, USA) to dissolve the RNA.
Complimentary DNA (cDNA) synthesis was carried
out using Enzynomics TOPscript™ cDNA Synthesis Kit,
according to manufacturer’s protocol. In brief, primer
annealing was done for 10 min at 23 °C, reverse tran-
scription for 60 min at 50 °C and reaction termination
for 5 min at 85 °C.
The qRT-PCR was performed on three marker genes
related to corneal keratocytes and its phenotypes i.e.
Aldehyde dehydrogenase (ALDH) as a marker for qui-
escent keratocytes, Vimentin as a marker for activated
fibroblast and Alpha smooth muscle actin (α-SMA) as a
marker for myofibroblast phenotype. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as the
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house keeping gene. The primers were designed from
NIH Genbank and tabulated (Table 1).
Two steps qRT-PCR was done with GENET BIO 2X
Prime Q-Master Mix (SYBR Green I) on Bio-Rad icycler
machine (Bio-Rad, USA). The reaction cycle conditions
were, cycle 1: 95 °C for 3 min (1x), cycle 2: 94 °C for
10 s, followed by 61 °C for 30 s (40x), followed by melt-
ing curve analysis.
The specificity and the PCR product size were con-
firmed by 2 % gel electrophoresis (Invitrogen, USA)
and was photographed by Polaroid MP4 camera (Polar-
oid DM Scientific).
Immunocytochemistry
Immunocytochemistry staining was carried out using
the Abcam Dako Immunostaining Kit protocol with
some modifications. The culture slides in each group
were fixed with 4 % paraformaldehyde at Day 3 (day of
confluence). The slides were treated with acetone at
4 °C for 5 min and followed by incubation with 0.03 %
hydrogen peroxide for 5 min at room temperature.
The slides were then heated for 20 min at 95 °C,
cooled with running water and soaked with primary
antibodies for 30 min.
Antibodies such as ALDH, Vimentin and α-SMA anti-
bodies (Abcam) with the dilution of 1:200 for ALDH
and α-SMA and 1:400 for Vimentin. Slides were then in-
cubated with secondary antibody for 30 min, followed by
DAB substrate for 10 min and counterstained with
haematoxylin (Sigma-Aldrich). The slides were examined
under a light microscope (Leica) with Image Analyser
5.2 Morphology Software.
Data analysis
All data were analysed using Statistical Package for So-
cial Sciences (SPSS) version 21. Values were expressed
as mean ± standard error of mean (SEM) using Student’s
t-test. A p value ≤ 0.05 was considered to be significant.
Results
MTT assay
Figure 1 showed the MTT assay of corneal keratocytes
cultured in serial dilutions of GH. Corneal keratocytes
showed higher proliferation in the BMS group compared
to the BM group in all GH concentrations (p < 0.05). GH
at the concentration of 0.0004 to 0.0031 % in both media
demonstrated a significant increase in keratocytes pro-
liferation compared to media devoid of GH (p < 0.05).
Keratocytes cultured in BMS medium supplemented
with 0.0004 to 0.0031 % GH significantly increased ker-
atocytes proliferation compared to BM supplemented
GH medium. There was no significant difference in cell
proliferation between 0.0004 and 0.0031 % GH in both
media. Therefore, GH at the concentration of 0.0015 %
was chosen as the optimal dose.
Cell morphology
Phase contrast micrographs of corneal keratocytes in
four different culture media with or without 0.0015 %
GH at Day 3 were shown in Fig. 2. The morphology of
corneal keratocytes cultured in BM and BM+ 0.0015 %
GH (Fig. 2a and b) demonstrated shorter and broader
cell with several cytoplasmic processes resembling den-
dritic cells. In contrast, corneal keratocytes cultured in
BMS with or without GH (Fig. 2c and d) exhibited elon-
gated, spindle-shaped cell resembling fibroblasts. Cell
density in BM (Fig. 2a) was lesser than BMS (Fig. 2c).
The addition of 0.0015 % GH in both media resulted in
higher cell density than their respective controls. Kerato-
cytes in BMS with 0.0015 % GH showed the highest cell
density and attained confluence (Fig. 2d).
Gene expression analyses
The expression of ALDH was higher in BM compared to
BMS with or without GH supplementation (Fig. 3b).
However, with the addition of 0.0015 % GH to both
media, the expression of ALDH gene increased signifi-
cantly (p < 0.05) compared to their respective controls.
Expression of ALDH was the highest in the BM group
supplemented with 0.0015 % GH.
There was a significant increase in the Vimentin ex-
pression of corneal keratocytes cultured in both BM and
BMS with 0.0015 % GH compared to their respective
controls (Fig. 3c). Keratocytes cultured in BMS supple-
mented with GH showed the highest Vimentin expres-
sion compared to the other groups.
Expression of α–SMA gene was higher in the BMS
groups compared to the BM groups (Fig. 3d). The
addition of 0.0015 % GH in both media demonstrated
significantly lower expression of α–SMA compared to
their respective controls (p < 0.05). The gene expression
of α–SMA was the lowest in the BM supplemented with
0.0015 % GH.
Table 1 Description of primers used in qRT-PCR




GAPDH F: caacgaatttggctacagca NM_001082253 186
R: aaactgtgaagaggggcaga
ALDH F: gagtggcatgattcagtgagc AY503694 186
R: gagtagtcgtcccctcttgga
Vimentin F: tgcaggaagagattgccttt AY465353 117
R: tgaggtcaggcttggagaca
α-SMA F: tcgacatcaggaaggacctct X60732 206
R: catctgctgaaaggtggacag
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Gel electrophoresis of ALDH, Vimentin and α–SMA
genes demonstrated the specificity and stability of corneal
keratocytes phenotypes in all culture groups (Fig. 4).
Immunocytochemistry (ICC)
The ICC slides were examined qualitatively according
to the presence of positive stained cells. This qualita-
tive procedure was based on previous research studies
[20, 21]. The intensity of the ALDH protein stain was
stronger in the BM group (Fig. 5a) compared to the
BMS group (Fig. 5c). The addition of 0.0015 % GH in
the BM group (Fig. 5b) exhibited stronger intensity of
this protein compared to that of GH supplemented
BMS group (Fig. 5d).
Corneal keratocytes showed positive stained cells for
Vimentin in all culture groups (Fig. 6a-d). However,
Fig. 1 Corneal keratocytes proliferation in (a) Basal medium (BM), (b) Basal medium with serum (BMS), supplemented with serial dilution of GH
and (c) comparison between the two media, BM and BMS. * denotes significant difference compare to control in the same group (p < 0.05), #
denotes significant difference at the same concentration in different groups (p < 0.05)
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corneal keratocytes in BMS supplemented with 0.0015 %
GH exhibited the strongest intensity of positive stained
Vimentin protein (Fig. 6d).
The intensity of the protein expression of α–SMA was
stronger in the BMS groups (Fig. 7c, d) compared to the
BM groups (Fig. 7a, b). The addition of 0.0015 % GH to
BM (Fig. 7b) exhibited weaker expression compared to
that of GH added BMS group (Fig. 7d).
Discussion
Cell proliferation is vital for wound healing and it re-
quires a considerable amount of glucose as the main
source of energy. Ex vivo cells obtain glucose from the
culture medium [22] and serum [23] for metabolic
process, growth and proliferation. Glucose is processed
in cell mitochondria to produce adenosine triphosphate
(ATP) [24], a form of energy which is crucially needed
for cellular metabolism including cell mitoses or prolif-
eration [25]. In the present study, the glucose content in
0.0015 % GH may have increased glycolytic enzymes
such as glyceryldehyde-3-phosphate dehydrogenase, lac-
tate dehydrogenase and glucose-6-phosphate dehydro-
genase. These enzymes are clues to on-going cellular
energy production [26]. GH may have induced protein
and DNA synthesis during the S phase of cell cycle, thus
enhancing cell mitoses and proliferation. The present
study demonstrated the addition of GH at the concen-
tration of 0.0015 % showed a positive role in ex vivo
corneal keratocytes proliferation. These findings are in
accordance to a previous report on Tualang honey in
serum enriched media which demonstrated positive
proliferative effects on osteoblast cell line [27].
The present study also showed the corneal keratocytes
morphology cultured in GH enriched media was compar-
able to controls. It was reported dendritic-shaped corneal
keratocytes cultured in serum free media [28] transformed
to fibroblastic-shaped when cultured in serum enriched
media [29]. The present study has proven that GH main-
tained corneal keratocytes morphology either in serum
free or serum enriched media. These findings indicate that
GH did not contain any elements that could cause un-
favourable morphology transformation of corneal kerato-
cytes. This attribute is important for its application in ex
vivo cell study or in cell-based therapy.
ALDH is a corneal crystalline that functions as a UV
protector, antioxidant and maintaining corneal transpar-
ency [30]. It is a molecular marker for quiescent kerato-
cytes [31]. The production of ALDH has been reported
to be located in the keratocytes nuclei and cytoplasm
[32]. As keratocytes transformed to fibroblast and myofi-
broblast during wound healing or due to the presence of
serum or growth factors in ex vivo culture medium, the
ALDH protein was no longer expressed [33]. The
present study demonstrated the capability of GH to pre-
serve more corneal crystalline which was evidenced by
higher gene expression of ALDH. These findings signi-
fied the potentiality of GH to be used in the treatment
of eye disorders, since it retains corneal transparency.
Fig. 2 Phase contrast micrographs of corneal keratocytes cultured in four different media. a Basal medium (BM), (b) BM + 0.0015 % GH, (c) Basal
medium with serum (BMS) and (d) BMS + 0.0015 % GH. Micrographs were taken at Passage 1 Day 3 of culture. Cell density was the least in BM
medium (a) and the highest in BMS + 0.0015 % GH (d). Corneal keratocytes cultured in BM only (a) and with GH (b) exhibited shorter and
broader cell morphology (thin arrow) compared to that of elongated and fibroblastic-shaped cells (thick arrow) in BMS medium (c) and with
GH (d). Magnification (x50)
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These findings are vital in the incorporation of ex vivo
corneal keratocytes in cell-based therapy for maintaining
normal clarity and function of the cornea.
Another crucial corneal keratocytes phenotype
marker is Vimentin which is an active keratocytes
phenotypes, fibroblasts, and represents a major intra-
cellular cytoskeletal protein of fibroblast [34]. Absence
of Vimentin in fibroblast resulted in weak intra skel-
etal structure, low fibroblast mechanical stability and
diminished contractility [35], thus delaying the
process of wound healing. Profusion of fibroblast was
also an advantage during corneal wound healing since
it promoted extracellular matrix productions during
wound closure [36]. The results of the present study
revealed high expression of Vimentin in GH added
media compared to controls with reciprocal reduction
of ALDH expression in the same media. Hence, GH
may have the potential to promote ex vivo corneal
wound healing by increasing transformation of more
quiescent keratocytes into active fibroblasts. Since
fibroblast transformation is induced in the presence
of platelet derived growth factor (PDGF) and fibro-
blast growth factor (FGF) [37], we hypothesise that
molecular components in GH may act in a similar
pathway as PDGF and FGF in inducing fibroblast
transformation.
The α–SMA is an intracellular actin isoform in myo-
fibroblast that involves in cell contractility, structure
and integrity [38]. Its high expression is usually closely
related to scar formation [39]. In a standard corneal
keratocytes culture, i.e. in BMS, the α–SMA expression
Fig. 3 Gene expression of (a) ALDH, (b) Vimentin and c α-SMA of
corneal keratocytes cultured in BM, BM + GH, BMS and BMS + GH. *
denotes significant difference in the same group (p < 0.05), # denotes
significant difference between different groups (p < 0.05)
Fig. 4 Gene expression of (a) GAPDH, b ALDH, c Vimentin and d
α-SMA of corneal keratocytes cultured in BM, BM + GH, BMS and
BMS + GH. * denotes significant difference in the same group
(p < 0.05), # denotes significant difference between different
groups (p < 0.05)
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Fig. 5 Immunocytochemistry of ALDH in four different media. a Basal medium (BM), (b) BM + 0.0015 % GH, (c) Basal medium with serum (BMS)
and (d) BMS + 0.0015 % GH. Corneal keratocytes expressed stronger intensity of ALDH antibody in basal medium (a) compared to serum
enriched basal medium (c) and also in the GH enriched basal medium (b) as compared to serum enriched medium with GH (d). Scale bar
represents 20 μm
Fig. 6 Immunocytochemistry of Vimentin in four different media. a Basal medium (BM), (b) BM + 0.0015 % GH, (c) Basal medium with serum
(BMS) and (d) BMS + 0.0015 % GH. Vimentin protein was expressed in all culture groups. The strongest intensity was observed in the serum
enriched medium with GH (d). Scale bar represents 20 μm
Yusof et al. BMC Complementary and Alternative Medicine  (2016) 16:76 Page 7 of 9
was usually high compared to the media without serum
due to the presence of transforming growth factor β
(TGF-β) [40]. However, in the present study, the
addition of GH in BMS significantly reduced the ex-
pression of α–SMA with a concurrent high expression
of Vimentin. This indicates the possibility of reversal
transformation of myofibroblast to fibroblast in GH
supplemented media. Reversal transformation is pos-
sible in the presence of FGF-heparin [41]. There is a
possibility of GH possessing the same growth factor or
any molecular component that may function in a simi-
lar way to FGF-heparin by promoting the reverse
transformation. The increased amount of active repair
phenotype, fibroblast and the decreased number of
scar phenotype, myofibroblast, may result in an accel-
erated corneal wound healing process with less risk of
developing corneal scar formation. To date, there is a
paucity of studies with regard to topical use of honey-
based eye drop in the treatment of corneal ulcer or
corneal cell-based therapy. Hence, the results of the
present study assume much importance with regard to
GH being used as a supplementary treatment for this
ailment.
The immunocytochemistry findings on ALDH, Vimentin
and α–SMA protein were in accordance with the respect-
ive gene analyses findings.
Conclusion
GH at the concentration of 0.0015 % stimulates corneal
keratocytes ex vivo proliferation while preserving corneal
crystalline, transforming more activated keratocytes;
fibroblast and producing less myofibroblast. These en-
couraging characteristics of corneal keratocytes cultured
in GH are fundamental findings that may open the door
for future studies in realizing GH as a potential nutri-
pharmaceutical agent to be administered in the form of
topical eye drop for the treatment of corneal wound
healing. In addition, the positive GH proliferative effects
may initiate a new paradigm in using GH as an effective
supplement into the standard corneal keratocytes culture
medium for corneal keratocytes expansion, corneal cell
transplantation or in the development of bioengineered
cornea. Further studies on exploration of GH compo-
nents are needed in order to ascertain the favourable ef-
fects on corneal keratocytes proliferation and desirable
phenotypes expression.
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